Area of research
Cardiology and Cardiovascular Medicine · Nephrology
Research interest
Research interests include Blood Pressure and Hypertension Studies, Chronic Kidney Disease and Diabetes, Hormonal Regulation and Hypertension, and Cardiac electrophysiology and arrhythmias.
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.
Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation.
Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
Description of Motor Stereotypies in Adolescents and Adults With Autistic Spectrum Disorder
Atrial Myopathy and Heart Failure: Immunomolecular Mechanisms and Clinical Implications.
Towards a better prevention in cardio-kidney metabolic syndrome: Role of aldosterone and albuminuria.
Is Fibroblast Growth Factor (FGF)23 a Player or a Trigger in Atrial Fibrillation?
Cardiovascular disease in women with early-onset preeclampsia: a matched case-control study.
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure.
Albumin Redox Modifications Promote Cell Calcification Reflecting the Impact of Oxidative Status on Aortic Valve Disease and Atherosclerosis.
Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study.
Hypertension and the kidney: an update.
The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease.
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients.
Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation.
Prevention of cardiorenal damage: importance of albuminuria.
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes.
Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation.
Cardiovascular and renal health: Preeclampsia as a risk marker.
Targeting the TWEAK-Fn14 pathway prevents dysfunction in cardiac calcium handling after acute kidney injury.
Global Oxidative Status Is Linked to Calcific Aortic Stenosis: The Differences Due to Diabetes Mellitus and the Effects of Metformin.
Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury.
Counteracting aldosterone in cardiorenal disease in type 2 diabetes through finerenone administration.
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
Klotho relieves inflammation and exerts a cardioprotective effect during renal ischemia/reperfusion-induced cardiorenal syndrome.
Unilateral Acute Renal Ischemia-Reperfusion Injury Induces Cardiac Dysfunction through Intracellular Calcium Mishandling.
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca<sup>2+</sup> Handling and NRF2 Activation.
Interplay between mineral bone disorder and cardiac damage in acute kidney injury: from Ca<sup>2+</sup> mishandling and preventive role of Klotho in mice to its potential mortality prediction in human.